Basilea Pharmaceutica AG (LON:0QNA)

Basilea Pharmaceutica AG Statistics

Total Valuation

LON:0QNA has a market cap or net worth of GBP 609.80 million. The enterprise value is 542.59 million.

Market Cap	609.80M
Enterprise Value	542.59M

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	12.29M
Shares Outstanding	n/a
Shares Change (YoY)	-1.23%
Shares Change (QoQ)	-2.36%
Owned by Insiders (%)	0.68%
Owned by Institutions (%)	34.69%
Float	12.21M

Valuation Ratios

The trailing PE ratio is 16.17 and the forward PE ratio is 12.92.

PE Ratio	16.17
Forward PE	12.92
PS Ratio	2.80
PB Ratio	5.09
P/TBV Ratio	5.10
P/FCF Ratio	10.94
P/OCF Ratio	10.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.13, with an EV/FCF ratio of 9.74.

EV / Earnings	14.39
EV / Sales	2.45
EV / EBITDA	10.13
EV / EBIT	10.91
EV / FCF	9.74

Financial Position

The company has a current ratio of 5.11, with a Debt / Equity ratio of 0.70.

Current Ratio	5.11
Quick Ratio	4.53
Debt / Equity	0.70
Debt / EBITDA	1.59
Debt / FCF	1.50
Interest Coverage	15.56

Financial Efficiency

Return on equity (ROE) is 38.52% and return on invested capital (ROIC) is 79.90%.

Return on Equity (ROE)	38.52%
Return on Assets (ROA)	12.10%
Return on Invested Capital (ROIC)	79.90%
Return on Capital Employed (ROCE)	22.45%
Weighted Average Cost of Capital (WACC)	6.34%
Revenue Per Employee	1.15M
Profits Per Employee	199,498
Employee Count	189
Asset Turnover	0.86
Inventory Turnover	5.46

Taxes

In the past 12 months, LON:0QNA has paid 5.28 million in taxes.

Income Tax	5.28M
Effective Tax Rate	12.28%

Stock Price Statistics

The stock price has increased by +7.64% in the last 52 weeks. The beta is 0.46, so LON:0QNA's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+7.64%
50-Day Moving Average	54.48
200-Day Moving Average	50.77
Relative Strength Index (RSI)	46.28
Average Volume (20 Days)	5,150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0QNA had revenue of GBP 217.74 million and earned 37.71 million in profits. Earnings per share was 2.94.

Revenue	217.74M
Gross Profit	81.67M
Operating Income	48.96M
Pretax Income	42.99M
Net Income	37.71M
EBITDA	50.66M
EBIT	48.96M
Earnings Per Share (EPS)	2.94

Balance Sheet

The company has 149.73 million in cash and 83.60 million in debt, with a net cash position of 66.13 million.

Cash & Cash Equivalents	149.73M
Total Debt	83.60M
Net Cash	66.13M
Net Cash Per Share	n/a
Equity (Book Value)	119.88M
Book Value Per Share	9.75
Working Capital	189.76M

Cash Flow

In the last 12 months, operating cash flow was 58.18 million and capital expenditures -2.45 million, giving a free cash flow of 55.72 million.

Operating Cash Flow	58.18M
Capital Expenditures	-2.45M
Depreciation & Amortization	1.72M
Net Borrowing	n/a
Free Cash Flow	55.72M
FCF Per Share	n/a

Margins

Gross margin is 37.51%, with operating and profit margins of 22.48% and 17.32%.

Gross Margin	37.51%
Operating Margin	22.48%
Pretax Margin	19.74%
Profit Margin	17.32%
EBITDA Margin	23.26%
EBIT Margin	22.48%
FCF Margin	25.59%

Dividends & Yields

LON:0QNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.23%
Shareholder Yield	1.23%
Earnings Yield	6.18%
FCF Yield	9.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0QNA has an Altman Z-Score of 0.15 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.15
Piotroski F-Score	5